AJOVista’s Voyager Therapeutics VYGR Stock Holding History

AJOVista’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4,573	Closed	-$38.6K	–	418
2023 Q4	$38.6K	Buy	+4,573	New	+$33.2K	0.05%	319

Other funds holding VYGR

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AJOVista's VYGR Position: Q1 2024 in Review

AJOVista sold out of Voyager Therapeutics (VYGR) in Q1 2024, closing a stake of 4,573 shares — an estimated $38.6K sold.

AJOVista first reported a position in VYGR in Q4 2023 and held it in 1 quarter. The position peaked at $38.6K in Q4 2023. 132 funds tracked by Wall St. Rank hold VYGR as of Q1 2024.

AJOVista reported no remaining Voyager Therapeutics position as of Q1 2024 after selling out during the quarter.
AJOVista sold 4,573 Voyager Therapeutics shares in Q1 2024, an estimated $38.6K.
AJOVista first reported a position in Voyager Therapeutics in Q4 2023 and held it in 1 quarter.
AJOVista's Voyager Therapeutics position peaked at $38.6K in Q4 2023.
132 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2024.

Based on AJOVista's 13F filing for Q1 2024, filed 10 May 2024.